Update on the role of drug therapy in non-ulcer dyspepsia

Reviews in Gastroenterological Disorders

Volumn 3, Issue 1, 2003, Pages 25-30

  Talley, Nicholas J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antidepressants; Dyspepsia; H2 receptor antagonists; Non ulcer dyspepsia; Prokinetics; Proton pump inhibitors

Indexed keywords

ALOSETRON; AMITRIPTYLINE; ANTACID AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BISMUTH; BUSPIRONE; CISAPRIDE; CITALOPRAM; DOMPERIDONE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METOCLOPRAMIDE; MIANSERIN; MISOPROSTOL; OMEPRAZOLE; PLACEBO; PROKINETIC AGENT; PROSTAGLANDIN DERIVATIVE; PROTON PUMP INHIBITOR; REBAMIPIDE; SEROTONIN 1 AGONIST; SEROTONIN UPTAKE INHIBITOR; STOMACH SECRETION INHIBITOR; SUCRALFATE; SUMATRIPTAN; TEGASEROD; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ALTERNATIVE MEDICINE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; COLITIS; CONSTIPATION; DATA ANALYSIS; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG MECHANISM; DRUG USE; DYSPEPSIA; ERADICATION THERAPY; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MEDICAL DECISION MAKING; PEPPER; PRESCRIPTION; PSYCHODYNAMICS; PSYCHOTHERAPY; REVIEW; STOMACH FUNDUS; SYMPTOMATOLOGY; TREATMENT PLANNING; UNITED STATES;

ANTI-ULCER AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CISAPRIDE; DOPAMINE ANTAGONISTS; DYSPEPSIA; GASTROINTESTINAL AGENTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METOCLOPRAMIDE; PROTON PUMPS; SUCRALFATE;

EID: 0037412462     PISSN: 1533001X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Talley NJ. Dyspepsia: how to manage and how to treat? Aliment Pharmacol Ther. 2002;16 (suppl 4):95-104.
2. Talley NJ. Therapeutic options in nonulcer dyspepsia. J Clin Gastroenterol. 2001;32:286-293.
3. Talley NJ, Stanghellini V, Heading RC, et al. Functional gastroduodenal disorders. Gut. 1999;45(suppl 2):II37-II42.
4. Finney JS, Kinnersley N, Hughes M, et al. Meta-analysis of anti-secretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroenterol. 1998;26:312-320.
5. Dobrilla G, Comberlato M, Steele A, Vallaperta P. Drug treatment of functional dyspepsia: a meta-analysis of randomized controlled clinical trials. J Clin Gastroenterol. 1989;11:169-177.
6. Redstone HA, Barrowman N, Veldhuyzen Van Zanten SJ. H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials. Aliment Pharmacol Ther. 2001;15:1291-1299.
7. Talley NJ, Meineche-Schmidt V, Pare P, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998;12:1055-1065.
8. Talley NJ, Lauritsen K. The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies. Gut. 2002;50(suppl 4):iv36-iv41.
9. Peura DA, Kovacs TO, Metz D, et al. Low dose lansoprazole: effective for non-ulcer dyspepsia (NUD). Gastroenterology. 2000;118(suppl 2):A439.
10. Wong WM, Wong BC, Hung WK, et al. Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients. Gut. 2002;51:502-506.
11. Blum AL, Arnold R, Stolte M, et al. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group. Gut. 2000;47:473-480.
12. Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol. 2001;96:689-696.
13. Soo S, Moayyedi P, Decks J, et al. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2000;(2):CD001960.
14. Talley NJ. Drug treatment of functional dyspepsia. Scand J Gastroenterol Suppl. 1991;182:47-60.
15. Talley NJ, Riff DS, Schwartz H, Marcuard SP. Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection. Aliment Pharmacol Ther. 2001;15:1603-1611.
16. Holtmann G, Gschossmann J, Karaus M, et al. Randomised double-blind comparison of simethicone with cisapride in functional dyspepsia. Aliment Pharmacol Ther. 1999;13:1459-1465.
17. Holtmann G, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther. 2002;16:1641-1648.
18. Moayyedi P, Soo S, Deeks J, et al. Systematic review and economic evaluation in Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ. 2000;321:659-664.
19. Laine L, Schonfeld P, Fennerty MB. Therapy for Helicobacter pylori in patients with non-ulcer dyspepsia: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2001;134:361-369.
20. Malfertheiner P, Megraud F, O'Morain C, et al; for The European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther. 2002;16:167-180.
21. Jackson JL, O'Malley PG, Thomkins G, et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med. 2000;108:65-72.
22. Tanum L, Malt UF. A new pharmacologic treatment for functional gastrointestinal disorders: a double-blind placebo controlled study with mianserin. Scand J Gastroenterol. 1996;31:318-325.
23. Mertz H, Fass R, Kodner A, et al. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol. 1998;93:160-165.
24. Tack J, Bisschops R, DeMarchi B. Causes and treatment of functional dyspepsia. Curr Gastroenterol Rep. 2001;3:503-508.
25. Soo S, Moayyedi P, Decks J, et al. Psychological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2001;(4):CD002301.
26. Bortolotti M, Coccia G, Grossi G, Miglioli M. The treatment of functional dyspepsia with red pepper. Aliment Pharmacol Ther. 2002;16:1075-1082.
27. May B, Kohler S, Schneider B. Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia. Aliment Pharmacol Ther. 2000;14:1671-1677.
28. Talley NJ, Van Zanten SV, Saez LR, et al. A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther. 2001;15:525-537.